School of Public Health: Rose Adam

(1) Rose AJ, Lee JS, Berlowitz DR, Liu W, Mitra A, Yu H. Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration. BMC Health Serv Res 2021;21(1).

(2) Rose AJ, Witt D, Azran C, Nissan R. Seven key parameters that facilitate clinical pharmacy practice: a comparison between Israel and the United States. Isr J Health Policy Res 2021;10(1).

(3) Rose AJ, Dunbar MS, Hughto JMW, Jasuja GK. Conceptual approach to developing quality measures for transgender patients. BMC Health Serv Res 2021;21(1).

(4) Peterson GG, Pu J, Magid DJ, Barterian L, Kranker K, Barna M, et al. Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol 2021;6(9):1050-1059.

(5) Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, et al. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Med Care 2021;59:S165-S169.

(6) Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses among US Transgender and Cisgender Adults. JAMA Netw Open 2021;4(2).

(7) Sanghai SR, Liu W, Wang W, Rongali S, Orkaby AR, Saczynski JS, et al. Prevalence of Frailty and Associations with Oral Anticoagulant Prescribing in Atrial Fibrillation. J Gen Intern Med 2021.

(8) Rose AJ. Pappas et al.: Cost-Effectiveness of Bridging Anticoagulation. J Gen Intern Med 2021;36(1):225.

(9) Rose AJ, Ellen ME. COVID-Related Disruption—Finding the Silver Lining. J Gen Intern Med 2020;35(11):3361-3362.

(10) Jasuja GK, De Groot A, Quinn EK, Ameli O, Hughto JMW, Dunbar M, et al. Beyond Gender Identity Disorder Diagnoses Codes: An Examination of Additional Methods to Identify Transgender Individuals in Administrative Databases. Med Care 2020;58(10):903-911.

(11) Ko D, Kapoor A, Rose AJ, Hanchate AD, Miller D, Winter MR, et al. Temporal trends in pharmacologic prophylaxis for venous thromboembolism after hip and knee replacement in older adults. Vasc Med 2020;25(5):450-459.

(12) Rongali S, Rose AJ, McManus DD, Bajracharya AS, Kapoor A, Granillo E, et al. Learning latent space representations to predict patient outcomes: Model development and validation. J Med Internet Res 2020;22(3).

(13) Faherty LJ, Rose AJ, Chappel A, Taplin C, Martineau M, Fischer SH. Assessing and Expanding the Evidence Base for Project ECHO and ECHO-Like Models: Findings of a Technical Expert Panel. J Gen Intern Med 2020;35(3):899-902.

(14) Jasuja GK, Ameli O, Reisman JI, Rose AJ, Miller DR, Berlowitz DR, et al. Health Outcomes among Long-term Opioid Users with Testosterone Prescription in the Veterans Health Administration. JAMA Netw Open 2019;2(12).

(15) McBain RK, Sousa JL, Rose AJ, Baxi SM, Faherty LJ, Taplin C, et al. Impact of Project ECHO Models of Medical Tele-Education: a Systematic Review. J Gen Intern Med 2019;34(12):2842-2857.

(16) Jasuja GK, Engle RL, Skolnik A, Rose AJ, Male A, Reisman JI, et al. Understanding the Context of High- and Low-Testosterone Prescribing Facilities in the Veterans Health Administration (VHA): a Qualitative Study. J Gen Intern Med 2019;34(11):2467-2474.

(17) Larochelle MR, Bernstein R, Bernson D, Land T, Stopka TJ, Rose AJ, et al. Touchpoints – Opportunities to predict and prevent opioid overdose: A cohort study. Drug Alcohol Depend 2019;204.

(18) Rose AJ, Goldberg R, McManus DD, Kapoor A, Wang V, Liu W, et al. Anticoagulant prescribing for non-valvular atrial fibrillation in the veterans health administration. J Am Heart Assoc 2019;8(17).

(19) Stopka TJ, Amaravadi H, Kaplan AR, Hoh R, Bernson D, Chui KKH, et al. Opioid overdose deaths and potentially inappropriate opioid prescribing practices (PIP): A spatial epidemiological study. Int J Drug Policy 2019;68:37-45.

(20) Rose AJ, Bayliss E, Baseman L, Butcher E, Huang W, Edelen MO. Feasibility of Distinguishing Performance among Provider Groups Using Patient-reported Outcome Measures in Older Adults with Multiple Chronic Conditions. Med Care 2019;57(3):180-186.

(21) Hailemariam DA, Shan X, Chung SH, Khasawneh MT, Lukesh W, Park A, et al. Developing an appropriate staff mix for anticoagulation clinics: functional job analysis approach. J Ind Eng Int 2019;15(1):103-118.

(22) Done N, Roy AM, Yuan Y, Pizer SD, Rose AJ, Prentice JC. Guideline-concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D. Health Serv Res 2019;54(1):128-138.

(23) Huang W, Rose AJ, Bayliss E, Baseman L, Butcher E, Garcia R-, et al. Adapting summary scores for the PROMIS-29 v2.0 for use among older adults with multiple chronic conditions. Qual Life Res 2019;28(1):199-210.

(24) Jasuja GK, Reisman JI, Wiener RS, Christopher ML, Rose AJ. Gender differences in prescribing of zolpidem in the Veterans Health Administration. Am J Managed Care 2019;25(3):E58-E65.

(25) Rose AJ, McBain R, Schuler MS, LaRochelle MR, Ganz DA, Kilambi V, et al. Effect of Age on Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011 to 2015. J Am Geriatr Soc 2019;67(1):128-132.

(26) Rose AJ, Timbie JW, Setodji C, Friedberg MW, Malsberger R, Kahn KL. Primary Care Visit Regularity and Patient Outcomes: an Observational Study. J Gen Intern Med 2019;34(1):82-89.

(27) Gillespie C, Rose AJ, Petrakis BA, Jones EA, Park A, McCullough MB. Qualitative study of patient experiences of responsibility in warfarin therapy. Am J Health-Syst Pharm 2018;75(22):1798-1804.

(28) Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, et al. Overdose risk for veterans receiving opioids from multiple sources. Am J Managed Care 2018;24(11).

(29) Rose AJ, Bayliss E, Huang W, Baseman L, Butcher E, García R-, et al. Evaluating the PROMIS-29 v2.0 for use among older adults with multiple chronic conditions. Qual Life Res 2018;27(11):2935-2944.

(30) Jasuja GK, Bhasin S, Rose AJ, Reisman JI, Skolnik A, Berlowitz DR, et al. Use of testosterone in men infected with human immunodeficiency virus in the veterans healthcare system. AIDS Care Psychol Socio-Med Asp AIDS HIV 2018;30(10):1207-1214.

(31) Rose AJ, Vaiana M. Evidence-Based Best Practices for Outpatient Management of Warfarin. Ann Pharmacother 2018;52(10):1042-1046.

(32) Rose AJ, Bernson D, Chui KKH, Land T, Walley AY, LaRochelle MR, et al. Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011–2015. J Gen Intern Med 2018;33(9):1512-1519.

(33) McBain R, Rose AJ, LaRochelle MR. The U.S. opioid epidemic: One disease, diverging tales. Prev Med 2018;112:176-178.

(34) Kim D, Lee KM, Freiman MR, Ryan Powell W, Klings ES, Rinne ST, et al. Phosphodiesterase-5 inhibitor therapy for pulmonary hypertension in the United States actual versus recommended use. Ann Am Thorac Soc 2018;15(6):693-701.

(35) Rose AJ, McCullough MB, Jasuja GK. A three-step health services research approach to improve prescribing. Healthcare 2018;6(2):135-138.

(36) Helfrich CD, Rose AJ, Hartmann CW, van Bodegom-Vos L, Graham ID, Wood SJ, et al. How the dual process model of human cognition can inform efforts to de-implement ineffective and harmful clinical practices: A preliminary model of unlearning and substitution. J Eval Clin Pract 2018;24(1):198-205.

(37) Lavelle TA, Rose AJ, Timbie JW, Setodji CM, Wensky SG, Giuriceo KD, et al. Utilization of health care services among Medicare beneficiaries who visit federally qualified health centers. BMC Health Serv Res 2018;18(1).

(38) Jasuja GK, Rose AJ. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: A Cross-Sectional Study. J Gen Intern Med 2017;32(10):1075.

(39) Rose AJ, Fischer SH, Paasche-Orlow MK. Medication reconciliation vs medication review - Reply. JAMA 2017;318(10):966.

(40) Jasuja GK, Bhasin S, Rose AJ, Reisman JI, Hanlon JT, Miller DR, et al. Provider and site-level determinants of testosterone prescribing in the veterans healthcare system. J Clin Endocrinol Metab 2017;102(9):3226-3233.

(41) Jasuja GK, Travison TG, Murabito JM, Davda MN, Rose AJ, Basaria S, et al. Circulating Estrogen Levels and Self-Reported Health and Mobility Limitation in Community-Dwelling Men of the Framingham Heart Study. J Gerontol Ser A Biol Sci Med Sci 2017;72(8):1137-1142.

(42) White Hughto JM, Rose AJ, Pachankis JE, Reisner SL. Barriers to gender transition-related healthcare: Identifying underserved transgender adults in Massachusetts. Transgender Health 2017;2(1):107-118.

(43) Rose AJ. Flying Blind: Don't Manage Warfarin Without a Registry. Jt Comm J Qual Patient Saf 2017;43(7):351-352.

(44) Rose AJ. Targeted approaches to improve outcomes for highest-cost patients. Isr J Health Policy Res 2017;6(1).

(45) Jasuja GK, Bhasin S, Rose AJ. Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes 2017;24(3):240-245.

(46) Kim EJ, Kim T, Paasche-Orlow MK, Rose AJ, Hanchate AD. Disparities in Hypertension Associated with Limited English Proficiency. J Gen Intern Med 2017;32(6):632-639.

(47) Rose AJ, McCullough MB. A Practical Guide to Using the Positive Deviance Method in Health Services Research. Health Serv Res 2017;52(3):1207-1222.

(48) Rose AJ, Fischer SH, Paasche-Orlow MK. Beyond medication reconciliation the correct medication list. JAMA 2017;317(20):2057-2058.

(49) Rose AJ, Park A, Gillespie C, Van Deusen Lukas C, Ozonoff A, Petrakis BA, et al. Results of a Regional Effort to Improve Warfarin Management. Ann Pharmacother 2017;51(5):373-379.

(50) Rose AJ, McCullough MB, Carter BL, Rudin RS. The Clinical Pharmacy Specialist: Part of the Solution. J Gen Intern Med 2017;32(4):375-377.

(51) Gören JL, Rose AJ, Ney JP. The business case for expanded clozapine utilization: In reply. Psychiatr Serv 2017;68(3):309-310.

(52) Jasuja GK, Bhasin S, Reisman JI, Hanlon JT, Miller DR, Morreale AP, et al. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study. J Gen Intern Med 2017;32(3):304-311.

(53) Fischer S, Rose A. Responsible e-prescribing needs e-discontinuation. JAMA 2017;317(5):469-470.

(54) Orkaby AR, Ozonoff A, Reisman JI, Miller DR, Zhao S, Rose AJ. Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis. J Am Geriatr Soc 2017;65(2):249-256.

(55) McCullough MB, Gillespie C, Petrakis BA, Jones EA, Park AM, Lukas CV, et al. Forming and activating an internal facilitation group for successful implementation: A qualitative study. Res Soc Adm Pharm 2017;13(5):1014-1027.

(56) Gören JL, Rose AJ, Engle RL, Smith EG, Christopher MLD, Rickles NM, et al. Organizational characteristics of veterans affairs clinics with high and low utilization of clozapine. Psychiatr Serv 2016;67(11):1189-1196.

(57) Gören JL, Rose AJ, Smith EG, Ney JP. The business case for expanded clozapine utilization. Psychiatr Serv 2016;67(11):1197-1205.

(58) Mantha S, Moll S, Hilden P, Devlin S, Rose A. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation: comment. J Thromb Haemost 2016;14(10):2083-2084.

(59) Ambrus DB, Reisman JI, Rose AJ. The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism. Thromb Res 2016;144:21-26.

(60) Rose AJ. What We Aren’t Measuring Yet: Applying Quality Measurement More Broadly. J Gen Intern Med 2016;31(8):821-822.

(61) Rose AJ, Reisman JI, Allen AL, Miller DR. Potentially inappropriate prescribing of direct-acting oral anticoagulants in the veterans health administration. Am J Pharm Benefits 2016;8(4):e75-e80.

(62) Kuhn H, Park A, Kim B, Lukesh W, Rose A. Proportion of work appropriate for pharmacy technicians in anticoagulation clinics. Am J Health-Syst Pharm 2016;73(5):322-327.

(63) Razouki Z, Knighton T, Martinello RA, Hirsch PR, McPhaul KM, Rose AJ, et al. Organizational factors associated with Health Care Provider (HCP) influenza campaigns in the Veterans health care system: A qualitative study. BMC Health Serv Res 2016;16(1).

(64) Rose AJ, Phibbs CS, Uyeda L, Su P, Edson R, Shih M-, et al. Does distance modify the effect of self-testing in oral anticoagulation? Am J Managed Care 2016;22(1):65-71.

(65) Rose AJ, Allen AL, Minichello T. A Call to Reduce the Use of Bridging Anticoagulation. Circ Cardiovasc Qual Outcomes 2016;9(1):64-67.

(66) McCullough MB, Petrakis BA, Gillespie C, Solomon JL, Park AM, Ourth H, et al. Knowing the patient: A qualitative study on care-taking and the clinical pharmacist-patient relationship. Res Soc Adm Pharm 2016;12(1):78-90.

(67) Rose AJ, Reisman JI, Razouki Z, Ozonoff A. Percent time in range with warfarin as a performance measure: How long a sampling frame is needed? Jt Comm J Qual Patient Saf 2015;41(12):561-568.

(68) Razouki Z, Burgess JF, Ozonoff A, Zhao S, Berlowitz D, Rose AJ. Improving Anticoagulation Measurement: Novel Warfarin Composite Measure. Circ Cardiovasc Qual Outcomes 2015;8(6):600-607.

(69) Rose AJ, Delate T, Ozonoff A, Witt DM. Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict Clinically Relevant Bleeding. Circ Cardiovasc Qual Outcomes 2015;8(5):524-531.

(70) Ozkaynak M, Johnson SA, Tulu B, Donovan JL, Kanaan AO, Rose A. Exploring the effect of complex patients on care delivery tasks. Int J Health Care Qual Assur 2015;28(5):494-509.

(71) Rao SR, Reisman JI, Kressin NR, Berlowitz DR, Ash AS, Ozonoff A, et al. Explaining Racial Disparities in Anticoagulation Control: Results From a Study of Patients at the Veterans Administration. Am J Med Qual 2015;30(3):214-222.

(72) Sarrazin MSV, Rose A. Safety of new oral anticoagulants. BMJ (Online) 2015;350.

(73) Shore S, Ho PM, Lambert-Kerzner A, Glorioso TJ, Carey EP, Cunningham F, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA 2015;313(14):1443-1450.

(74) McCullough MB, Solomon JL, Petrakis BA, Park AM, Ourth H, Morreale AP, et al. Balancing Collaborative and Independent Practice Roles in Clinical Pharmacy: A Qualitative Research Study. Ann Pharmacother 2015;49(2):189-195.

(75) McCullough MB, Chou AF, Solomon JL, Petrakis BA, Kim B, Park AM, et al. The interplay of contextual elements in implementation:An ethnographic case study. BMC Health Serv Res 2015;15(1).

(76) Vaughan Sarrazin MS, Rose A. Safety of new oral anticoagulants. BMJ 2015;350:h1679.

(77) Jasuja GK, Bhasin S, Reisman JI, Berlowitz DR, Rose AJ. Ascertainment of testosterone prescribing practices in the VA. Med Care 2015;53(9):746-752.

(78) Kim E-, Ozonoff A, Hylek EM, Berlowitz DR, Ash AS, Miller DR, et al. Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin. Thromb Haemost 2015;114(1):70-77.

(79) Kim B, Shaikh OA, Rose AJ. Examining warfarin dosing decisions to improve anticoagulation management. J Pharm Technol 2014;30(5):168-174.

(80) Razouki Z, Ozonoff A, Zhao S, Jasuja GK, Rose AJ. Improving quality measurement for anticoagulation adding international normalized ratio variability to percent time in therapeutic range. Circ Cardiovasc Qual Outcomes 2014;7(5):664-669.

(81) Rose AJ. Warfarin: Not dead yet. J Gen Intern Med 2014;29(3):425-426.

(82) Efird LM, Mishkin DS, Berlowitz DR, Ash AS, Hylek EM, Ozonoff A, et al. Stratifying the risks of oral anticoagulation in patients with liver disease. Circ Cardiovasc Qual Outcomes 2014;7(3):461-467.

(83) Paradise HT, Berlowitz DR, Ozonoff A, Miller DR, Hylek EM, Ash AS, et al. Outcomes of anticoagulation therapy in patients with mental health conditions. J Gen Intern Med 2014;29(6):855-861.

(84) Razouki Z, Ozonoff A, Zhao S, Rose AJ. Pathways to poor anticoagulation control. J Thromb Haemost 2014;12(5):628-634.

(85) Cancino RS, Hylek EM, Reisman JI, Rose AJ. Comparing patient-level and site-level anticoagulation control as predictors of adverse events. Thromb Res 2014;133(4):652-656.

(86) Efird LM, Miller DR, Ash AS, Berlowitz DR, Ozonoff A, Zhao S, et al. Identifying the risks of anticoagulation in patients with substance abuse. J Gen Intern Med 2013;28(10):1333-1339.

(87) Jasuja GK, Travison TG, Davda M, Rose AJ, Zhang A, Kushnir MM, et al. Circulating estrone levels are associated prospectively with diabetes risk in men of the framingham heart study. Diabetes Care 2013;36(9):2591-2596.

(88) Jasuja GK, Bhasin S, Reisman JI, Rose AJ. Wide variations in use of testosterone therapy among VHA facilities. Am J Pharm Benefits 2013;5(5):e122-e128.

(89) Jasuja GK, Travison TG, Davda M, Murabito JM, Basaria S, Zhang A, et al. Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the framingham heart study. J Gerontol Ser A Biol Sci Med Sci 2013;68(6):733-740.

(90) Preparing for the worst: A key for better anticoagulation management. IIE Annual Conference and Expo 2013; 2013.

(91) Wasserman MS, Rose AJ. An unusual presenting complaint for herpes zoster. Am J Med 2013;126(6):e3.

(92) Rose AJ, Miller DR, Ozonoff A, Berlowitz DR, Ash AS, Zhao S, et al. Gaps in monitoring during oral anticoagulation: Insights into care transitions, monitoring barriers, and medication nonadherence. Chest 2013;143(3):751-757.

(93) Jasuja GK, Reisman JI, Miller DR, Berlowitz DR, Hylek EM, Ash AS, et al. Identifying major hemorrhage with automated data: Results of the Veterans Affairs Study to Improve Anticoagulation (VARIA). Thromb Res 2013;131(1):31-36.

(94) Rose AJ. Improving the management of warfarin may be easier than we think. Circulation 2012;126(19):2277-2279.

(95) Rose AJ, Petrakis BA, Callahan P, Mambourg S, Patel D, Hylek EM, et al. Organizational characteristics of high- and low-performing anticoagulation clinics in the veterans health administration. Health Serv Res 2012;47(4):1541-1560.

(96) Rose AJ, Berlowitz DR, Miller DR, Hylek EM, Ozonoff A, Zhao S, et al. INR targets and site-level anticoagulation control: Results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2012;10(4):590-595.

(97) Rose AJ, Ozonoff A, Berlowitz DR, Ash AS, Reisman JI, Hylek EM. Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: Results from the Veterans Affairs Study to Improve Anticoagulation. Chest 2011;140(2):359-365.

(98) Rose AJ, Berlowitz DR, Ash AS, Ozonoff A, Hylek EM, Goldhaber-Fiebert JD. The business case for quality improvement oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes 2011;4(4):416-424.

(99) Rose AJ, Glickman ME, D'Amore MM, Orner MB, Berlowitz D, Kressin NR. Effects of Daily Adherence to Antihypertensive Medication on Blood Pressure Control. J Clin Hypertens 2011;13(6):416-421.

(100) Rose AJ, Hylek EM, Berlowitz DR, Ash AS, Reisman JI, Ozonoff A. Prompt repeat testing after out-of-range inr values a quality indicator for anticoagulation care. Circ Cardiovasc Qual Outcomes 2011;4(3):276-282.

(101) Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Callahan PP, et al. Relevance of current guidelines for organizing an anticoagulation clinic. Am J Managed Care 2011;17(4):284-289.

(102) Rose AJ, Hylek EM, Ozonof A, Ash AS, Reisman JI, Berlowitz DR. Risk-Adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation results of the veterans affairs study to improve anticoagulation (varia). Circ Cardiovasc Qual Outcomes 2011;4(1):22-29.

(103) Rose AJ, Hylek EM. High blood pressure while taking antithrombotic medication is associated with an increased risk of developing intracranial haemorrhage. Evid -Based Med 2010;15(6):189-190.

(104) Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010;8(10):2182-2191.

(105) Manze M, Rose AJ, Orner MB, Berlowitz DR, Kressin NR. Understanding racial disparities in treatment intensification for hypertension management. J Gen Intern Med 2010;25(8):819-825.

(106) Rose AJ. Patient education: The missing link in improving quality of oral anticoagulation. Cardiology 2010;116(1):59-60.

(107) Rose AJ, Ozonoff A, Henault LE, Hylek EM. Anticoagulation for valvular heart disease in community-based practice. Thromb Haemost 2010;103(2):329-337.

(108) Rose AJ, Ozonoff A, Grant RW, Henault LE, Hylek EM. Epidemiology of subtherapeutic anticoagulation in the United States. Circ Cardiovasc Qual Outcomes 2009;2(6):591-597.

(109) Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Intensifying therapy for hypertension despite suboptimal adherence. Hypertension 2009;54(3):524-529.

(110) Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Comparing methods of measuring treatment intensification in hypertension care. Circ Cardiovasc Qual Outcomes 2009;2(4):385-391.

(111) Rose AJ, Hermos JA, Frayne SM, Pogach LM, Berlowitz DR, Miller DR. Does opioid therapy affect quality of care for diabetes mellitus? Am J Managed Care 2009;15(4):217-224.

(112) Hylek EM, Rose AJ. Understanding low INR in clinical practice. Thromb Haemost 2009;101(3):417-418.

(113) Berz JPB, Johnston K, Backus B, Doros G, Rose AJ, Pierre S, et al. The influence of black race on treatment and mortality for early-stage breast cancer. Med Care 2009;47(9):986-992.

(114) Rose AJ, Berlowitz DR, Frayne SM, Hylek EM. Measuring quality of oral anticoagulation care: Extending quality measurement to a new field. Jt Comm J Qual Patient Saf 2009;35(3):146-155.

(115) Rose AJ, Ozonoff A, Berlowitz DR, Henault LE, Hylek EM. Warfarin dose management affects INR control. J Thromb Haemost 2009;7(1):94-101.

(116) Rose AJ, Ozonoff A, Henault LE, Hylek EM. Warfarin for atrial fibrillation in community-based practise. J Thromb Haemost 2008;6(10):1647-1654.

(117) Rose AJ, Sacks NC, Deshpande AP, Griffin SY, Cabral HJ, Kazis LE. Single-change items did not measure change in quality of life. J Clin Epidemiol 2008;61(6):603-608.

(118) Rose AJ, Shimada SL, Rothendler JA, Reisman JI, Glassman PA, Berlowitz DR, et al. The accuracy of clinician perceptions of "usual" blood pressure control. J Gen Intern Med 2008;23(2):180-183.

(119) Rose AJ, Sharman JP, Ozonoff A, Henault LE, Hylek EM. Effectiveness of warfarin among patients with cancer. J Gen Intern Med 2007;22(7):997-1002.

(120) Rose AJ, Backus BM, Gershman ST, Santos P, Ash AS, Battaglia TA. Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002. Med Care 2007;45(5):440-447.

(121) Rose AJ, Berlowitz DR, Orner MB, Kressin NR. Understanding uncontrolled hypertension: is it the patient or the provider? J Clin Hypertens (Greenwich) 2007;9(12):937-943.

(122) Rose AJ, Stein MR, Arnsten JH, Saitz R. Teaching internal medicine resident physicians about alcoholics anonymous: A pilot study of an educational intervention. Subst Abuse 2006;27(3):5-11.